No Detail Found!

Borderline-resectable Undi erentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: upfront Surgery or Neoadjuvant Chemotherapy?

Author(s)
Alper Sozutek Department of Gastroenterological Surgery, University of Health Sciences, Adana City Training and Research Hospital,Adana,Turkey
Elife Aktas Department of Pathology, University of Health Sciences, Adana City Training and Research Hospital,Adana,Turkey
Abstract
Undifferentiated carcinoma with osteoclast-like giant cells (UDC-OGC) of the pancreas is an extremely rare entity, thus an obvious discrepancy regarding their treatment approach exists in the current literature. A 52-year female patient with a twoweeks history of jaundice was diagnosed as borderline-resectable pancreatic mass located in the uncinate process of a size of 5×4 cm. Pancreaticoduodenectomy (PD) with partial portal vein resection was successfully performed following neoadjuvant chemotherapy (NACT). The pathology was interpreted as UDC-OGC without lymph node involvement. Considering their aggressive behavior, NACT followed by surgery seems to be a good option in case of borderline-resectable UDC-OGC.
Publication Details
Page(s) 934-937
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 7, Year: 2022

Request the full text from PASTIC

Keywords
Pancreatic Neoplasms, neoadjuvant chemotherapy, giant cells, Undi erentiated carcinoma, Pancreaticoduodenectomy
0

Citations

0

Downloads

95

Views